Document Detail


Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study.
MedLine Citation:
PMID:  23311768     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objectives: Patients with rheumatoid arthritis (RA) have increased cardiovascular risk. The aim of the present study was the assessment of low density lipoprotein (LDL) and high density lipoprotein (HDL) subclass distribution in patients with early RA (ERA, n = 30) compared with age- and sex-matched healthy subjects (n = 30), as well the effect of treatment for 12 months with the disease-modifying anti-rheumatic drugs (DMARDs) methotrexate and prednisone in this distribution. Method: LDL and HDL subclass distribution was determined using a polyacrylamide gel-tube electrophoresis method. Results: ERA patients exhibited increased levels of inflammatory markers and high disease activity score. ERA patients had higher serum levels of total cholesterol (TC), LDL cholesterol (LDL-C), and triglycerides (TG) whereas their serum HDL cholesterol (HDL-C) levels were significantly lower compared with controls. ERA patients exhibited significantly higher plasma levels of small dense LDL-C (sdLDL-C), leading to a significantly decreased mean LDL diameter. ERA patients had significantly decreased small HDL particles (HDL-3) concentration whereas serum levels of large HDL particles (HDL-2) did not differ compared with controls. Treatment with DMARDs resulted in a significant decrease in inflammatory markers and disease activity, along with a significant increase in HDL-C serum levels. The concentration of sdLDL-C did not change significantly during treatment. We observed a significant increase in the levels of large HDL-2 whereas the concentration of small HDL-3 did not significantly change. Conclusions: Patients with ERA have increased sdLDL-C levels and decreased HDL-C levels because of decreased concentration of the small HDL-3 subclass. The administration of DMARDs induced a significant increase in HDL-C levels, which was attributed to the increase in large HDL-2 serum concentration.
Authors:
Td Filippatos; Cs Derdemezis; Pv Voulgari; V Tsimihodimos; Ms Elisaf; Ad Tselepis; Aa Drosos
Related Documents :
23361158 - Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in p...
22994438 - Association between systemic neutrophil gelatinase-associated lipocalin and anemia, rel...
23767648 - Langmuir oscillations in a nonextensive electron-positron plasma.
24160198 - Algorithm for the early diagnosis of vitamin b12 deficiency in elderly people.
18606408 - Endocrine and behavioral changes in male african elephants: linking hormone changes to ...
1291858 - Severe hypophosphatemia in a patient with anorexia nervosa during oral feeding.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-14
Journal Detail:
Title:  Scandinavian journal of rheumatology     Volume:  -     ISSN:  1502-7732     ISO Abbreviation:  Scand. J. Rheumatol.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0321213     Medline TA:  Scand J Rheumatol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Internal Medicine, Medical School , Ioannina , Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mortality related to pancreas disease in Norwegian farmed salmonid fish, Salmo salar L. and Oncorhyn...
Next Document:  Impaction grafting in the femur in cementless modular revision total hip arthroplasty: a descriptive...